Botanical Drug Product Guidance Sets Foreign Marketing Data Requirements

Companies interested in submitting an IND to conduct clinical trials on a botanical that has only been extensively available abroad must supply the agency with sales data as well as information on consumer exposure and adverse events.

More from Archive

More from Pink Sheet